{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:55:09Z","timestamp":1786996509254,"version":"build-2736575974"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007871","name":"European College of Neuropsychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NCT01012167"],"award-info":[{"award-number":["NCT01012167"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1P50 MH082999"],"award-info":[{"award-number":["1P50 MH082999"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.schres.2017.01.028","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T03:47:34Z","timestamp":1485316054000},"page":"141-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study"],"prefix":"10.1016","volume":"188","author":[{"given":"Alex S.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle R.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack J.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.01.028_bb9000","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1037\/0021-843X.103.2.371","article-title":"Evaluation of social problem solving in schizophrenia","volume":"103","author":"Bellack","year":"1994","journal-title":"J. Abnorm. Psychol."},{"issue":"10","key":"10.1016\/j.schres.2017.01.028_bb0005","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1176\/appi.ajp.2007.06081358","article-title":"The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments","volume":"164","author":"Buchanan","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.028_bb0010","series-title":"A Randomized Clinical Trial of Oxytocin and Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia","author":"Buchanan","year":"2016"},{"issue":"3","key":"10.1016\/j.schres.2017.01.028_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/YCO.0000000000000056","article-title":"Automated computerized analysis of speech in psychiatric disorders","volume":"27","author":"Cohen","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.01.028_bb0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2013.05.003","article-title":"Computerized facial analysis for understanding constricted\/blunted affect: initial feasibility, reliability, and validity data","volume":"148","author":"Cohen","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.01.028_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1037\/abn0000136","article-title":"Vocal expression in schizophrenia: less than meets the ear","volume":"125","author":"Cohen","year":"2016","journal-title":"J. Abnorm. Psychol."},{"issue":"2","key":"10.1016\/j.schres.2017.01.028_bb0030","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"issue":"4","key":"10.1016\/j.schres.2017.01.028_bb0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0963721411417547","article-title":"The role of oxytocin in human affect a novel hypothesis","volume":"20","author":"Kemp","year":"2011","journal-title":"Curr. Dir. Psychol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.01.028_bb0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2013.01.001","article-title":"Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study","volume":"145","author":"Lee","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.01.028_bb0045","series-title":"FaceReader 4.0","author":"Noldus Information Technology","year":"2010"},{"issue":"5","key":"10.1016\/j.schres.2017.01.028_bb0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00406-015-0634-9","article-title":"Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"266","author":"Oya","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:53:57Z","timestamp":1778763237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":11,"alternative-id":["S0920996417300415"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.028","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}